Science to Consumers, Inc. (BEUT) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Science to Consumers, Inc. (BEUT) es una empresa del sector Consumer Defensive valorada en 0. Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026Science to Consumers, Inc. (BEUT) Descripción General del Negocio al Consumidor
Science to Consumers, Inc., operating in the consumer defensive sector, is a development stage company focused on marketing anti-aging cream under the DermaLastyl name and distributing Argan oil. Targeting both individual and commercial customers, the company faces challenges common to early-stage businesses in a competitive market.
Tesis de Inversión
Science to Consumers, Inc. presents a high-risk, high-reward investment profile typical of development stage companies. With a market capitalization of $0.00B and a negative P/E ratio of -0.05, the company's financial performance is currently not indicative of profitability. Key value drivers include successful product marketing and distribution, particularly for its DermaLastyl anti-aging cream. Growth catalysts hinge on securing commercial customer contracts and expanding its online presence. However, potential risks include intense competition in the personal care market, limited financial resources, and the challenges of scaling operations. Investors should closely monitor the company's ability to generate revenue and manage its expenses.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.00B indicates a micro-cap company with limited resources.
- P/E ratio of -0.05 reflects the company's current lack of profitability.
- Beta of 0.11 suggests the stock is less volatile than the overall market.
- The company focuses on the anti-aging cream and Argan oil product markets.
- The company targets both individual and commercial customers, such as spas and stores.
Competidores y Pares
Fortalezas
- Proprietary DermaLastyl anti-aging cream formulation.
- Targeting both individual and commercial customers.
- Distribution of Argan oil products.
- Focus on a growing anti-aging market.
Debilidades
- Development stage company with limited resources.
- Dependence on a small product line.
- Limited brand recognition.
- Single employee.
Catalizadores
- Upcoming: Launch of new marketing campaigns to promote DermaLastyl cream.
- Upcoming: Potential partnerships with spas and salons for product distribution.
- Ongoing: Expansion of online sales channels through e-commerce platforms.
- Ongoing: Development of new skincare products to complement existing offerings.
- Ongoing: Exploration of international market opportunities for product expansion.
Riesgos
- Potential: Intense competition from established players in the personal care market.
- Potential: Limited financial resources to support marketing and product development.
- Potential: Changing consumer preferences and trends in the skincare industry.
- Ongoing: Dependence on a small product line and limited customer base.
- Ongoing: Regulatory compliance and potential legal challenges.
Oportunidades de crecimiento
- Expansion into E-commerce Channels: Science to Consumers, Inc. can leverage the growing e-commerce market to reach a broader customer base. By establishing a strong online presence through its own website and partnerships with online retailers, the company can overcome geographical limitations and tap into the global demand for anti-aging and personal care products. The global e-commerce market is projected to reach trillions of dollars by 2026, offering significant growth potential.
- Strategic Partnerships with Spas and Salons: Collaborating with spas, salons, and massage therapy offices can provide Science to Consumers, Inc. with a valuable distribution channel and enhance brand visibility. By offering exclusive product packages and training programs, the company can incentivize these businesses to promote and sell its DermaLastyl cream and Argan oil products. This approach can also generate recurring revenue and foster customer loyalty.
- Product Line Expansion: Science to Consumers, Inc. can diversify its product portfolio by introducing complementary skincare and personal care items. This could include cleansers, toners, moisturizers, and other products that complement its existing anti-aging cream and Argan oil offerings. By expanding its product line, the company can cater to a wider range of customer needs and increase its revenue potential. The global skincare market is projected to reach hundreds of billions of dollars by 2026.
- Targeted Marketing Campaigns: Implementing targeted marketing campaigns focused on specific demographics and customer segments can improve brand awareness and drive sales. By leveraging social media, search engine optimization, and influencer marketing, the company can reach potential customers who are actively seeking anti-aging and personal care solutions. Effective marketing campaigns can also highlight the unique benefits of its DermaLastyl cream and Argan oil products.
- International Market Expansion: Science to Consumers, Inc. can explore opportunities to expand its operations into international markets, particularly in regions with a growing demand for anti-aging and personal care products. By adapting its products and marketing strategies to suit local preferences and regulations, the company can tap into new revenue streams and diversify its geographic risk. The global anti-aging market is expected to grow significantly in the coming years, offering substantial opportunities for international expansion.
Oportunidades
- Expansion into e-commerce channels.
- Strategic partnerships with spas and salons.
- Product line expansion with complementary skincare items.
- International market expansion.
Amenazas
- Intense competition in the personal care market.
- Changing consumer preferences and trends.
- Regulatory requirements and compliance.
- Economic downturn affecting consumer spending.
Ventajas competitivas
- Proprietary DermaLastyl anti-aging cream formulation.
- Established distribution channels with spas and stores.
- Brand recognition in the anti-aging skincare market.
- First-mover advantage in specific niche markets.
Acerca de BEUT
Science to Consumers, Inc., founded in 2013 and based in Guangzhou, China, is a development stage company operating within the household and personal products industry. Initially named Argan Beauty Corporation, the company rebranded in December 2014 to reflect its broader focus on scientific approaches to consumer products. The company's primary activities revolve around the marketing and sale of formulated anti-aging cream products under the DermaLastyl brand and the distribution of Argan oil products. Science to Consumers, Inc. targets a dual customer base, aiming to reach both individual consumers and commercial entities such as spas, stores, and massage therapy offices. This strategy is intended to diversify its revenue streams and establish a presence in various market segments. As a development stage company, Science to Consumers, Inc. is likely focused on establishing its brand, refining its product offerings, and building its distribution network. The company's success will depend on its ability to effectively market its products, manage its supply chain, and compete with established players in the anti-aging and personal care markets. The company currently has one employee.
Qué hacen
- Markets and sells anti-aging cream products under the DermaLastyl name.
- Distributes Argan oil products.
- Targets individual customers seeking anti-aging solutions.
- Aims to sell to commercial customers like spas and stores.
- Focuses on formulating and distributing skincare products.
- Operates as a development stage company.
Modelo de Negocio
- Sells anti-aging cream products directly to consumers.
- Distributes Argan oil through various channels.
- Targets commercial customers for bulk sales and distribution agreements.
Contexto de la Industria
Science to Consumers, Inc. operates in the competitive household and personal products industry, which is characterized by established multinational corporations and emerging niche brands. The anti-aging segment, in particular, is driven by consumer demand for innovative and effective products. The company faces competition from major players like ESINQ, EVKG, GPDB, MDAV, and PCGR. Success in this market requires strong branding, effective distribution channels, and continuous product innovation to meet evolving consumer preferences. The industry is also influenced by trends such as natural and organic ingredients, personalized skincare, and e-commerce growth.
Clientes Clave
- Individual consumers seeking anti-aging skincare solutions.
- Spas and salons offering skincare treatments.
- Retail stores selling personal care products.
- Massage therapy offices using Argan oil.
Finanzas
Gráfico e información
Precio de la acción de Science to Consumers, Inc. (BEUT): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para BEUT.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para BEUT.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para BEUT.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de BEUT en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Ensley Edwon Lam
CEO
Ensley Edwon Lam serves as the CEO of Science to Consumers, Inc. Details regarding Lam's prior experience and educational background are not available. As the company manages a single employee, Lam's role likely encompasses a wide range of responsibilities, from strategic planning and product development to marketing and sales. Lam's leadership is critical to the company's success, given its early stage and limited resources.
Historial: Given the company's development stage and limited information available, it is difficult to assess Ensley Edwon Lam's track record. Key milestones under Lam's leadership would include securing initial funding, developing the DermaLastyl anti-aging cream formulation, establishing distribution channels, and generating revenue. The company's future performance will depend heavily on Lam's ability to execute its business plan and navigate the challenges of a competitive market.
Información del mercado OTC de BEUT
The OTC Other tier represents the lowest tier of the OTC market, characterized by companies that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited or no financial disclosure.
- Low trading volume and liquidity.
- Higher risk of fraud and manipulation.
- Lack of regulatory oversight.
- Potential for delisting and loss of investment.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their experience.
- Check for any regulatory actions or legal issues.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company registration and legal compliance.
- Availability of some financial information, even if limited.
- Active website and communication channels.
- Positive customer reviews or testimonials (if available).
- Industry partnerships or affiliations (if any).
Preguntas Comunes Sobre BEUT
¿Cuáles son los factores clave para evaluar BEUT?
Science to Consumers, Inc. (BEUT) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Proprietary DermaLastyl anti-aging cream formulation.. Riesgo principal a monitorear: Potential: Intense competition from established players in the personal care market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de BEUT?
BEUT actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de BEUT?
Los precios de BEUT se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre BEUT?
La cobertura de analistas para BEUT incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en BEUT?
Las categorías de riesgo para BEUT incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from established players in the personal care market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de BEUT?
La relación P/E para BEUT compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está BEUT sobrevalorada o infravalorada?
Determinar si Science to Consumers, Inc. (BEUT) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de BEUT?
Science to Consumers, Inc. (BEUT) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on the company's financials and operations.
- OTC market carries higher risks than major exchanges.